Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2016 - 06/30/2016

Lobbyist name	Geoffrey A. Gallo
Business name	AstraZeneca Pharmaceuticals, LP
Address	3 Merles Lane
City, state, zip code	Stratham, NH 03885
Country	US
Agent type	Both
Phone	603-772-1559

Operating Expenses

Date	Recipient	Type of expense	Amount
1/1/2016-6/30/2016		Advertising expenses	$0.00
1/1/2016-6/30/2016		Photocopies, scans	$0.00
1/1/2016-6/30/2016		Computer equipment, supplies	$0.00
1/1/2016-6/30/2016		Professional dues	$0.00
1/1/2016-6/30/2016		Fax charges	$0.00
1/1/2016-6/30/2016		Internet fees	$0.00
1/1/2016-6/30/2016		Legal fees	$0.00
1/1/2016-6/30/2016	United States Postal Service	Postage, shipping, delivery	$34.00
1/1/2016-6/30/2016		Office supplies, equipment	$0.00
1/1/2016-6/30/2016		Printing expenses	$0.00
1/1/2016-6/30/2016		Public relations expenses	$0.00
1/1/2016-6/30/2016		Rent	$0.00
1/1/2016-6/30/2016		Office and support staff salaries	$0.00
1/1/2016-6/30/2016		Professional subscriptions	$0.00
1/1/2016-6/30/2016		Taxes	$0.00
1/1/2016-6/30/2016	Verizon Wireless	Telephone, cell phone, handheld	$225.00
1/1/2016-6/30/2016		Utilities (heat, water, electricity)	$0.00
1/1/2016-6/30/2016		Other operating expenses	$0.00
		Total operating expenses	$259.00

Activities, Bill Numbers and Titles

Client: AstraZeneca Pharmaceuticals, LP

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Senate Bill	541	An Act concerning out-of-pocket expenses for prescription drug coverage.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	965	An Act to ensure effective health care cost control.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	643	An Act relative to mandated benefits.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	639	An Act relative to mandatory prescription drug coverage.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	977	An Act relative to the base premium rate discount of selective and tiered network products.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	1165	An Act relative to the dispensing of certain cancer related drugs.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Executive		Senate budget amendment on step therapy for medications. Senate budget amendment seeking to establish and/or study the feasibility of a statewide drug bulk-purchasing program. -Senate budget amendment for the operation of an evidence-based outreach and education program designed to provide information and education on the therapeutic and cost-effective utilization of prescription drugs to physicians, pharmacists and other health care professionals authorized to prescribe and dispense prescription drugs.	Oppose	$2,400.00	I had no business association with any public official I lobbied during this period.
House Bill	976	An Act further regulating the substitution of interchangeable biosimilar medications.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	992	An Act to control costs of health care - mandate review.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Executive		Supported the House budget amendment that mandates the use of net drug prices for all calculations for the total health care expense in MA also known as cost trends accuracy. In the Senate budget; the inclusion of an industry representative on the committee that will conduct a study pertaining to the potential statewide drug bulk-purchasing program. Supported the House budget amendment that placed a 2-year extension on the current drug co-pay assistance law until July 2017. Subsequently, supported the Senate Budget amendment that extended the co-pay assistance law to June 30, 2019. Promoting the overall clinical value of prescription medicines.	Support	$12,000.00	I had no business association with any public official I lobbied during this period.
Senate Bill	1187	An Act to Prevent Undue Influence on Prescriber Behavior.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	1003	An Act relative to provide immediate relief to businesses on Health Care Costs.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	792	An Act relative to ensuring transparency of health plan formularies.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1048	An Act to promote transparency and cost control of pharmaceutical drug prices.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	2073	An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	1018	An Act relative to health care cost transparency.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1186	An Act to restore integrity in the marketing of pharmaceutical products and medical devices.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	3270	An Act establishing a right to try.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	1894	An Act relative to Retail Pharmacy Discounts and Co-Pay Assistance.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1233	An Act Establishing and Financing a Drug Collection and Disposal Program.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
Senate Bill	579	An Act establishing Medicare for all in Massachusetts.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	1915	An Act to ensure patient medication adherence.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1508	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
Senate Bill	581	An Act to ensure access to medications.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	828	An Act relative to patient financial protection.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1177	An Act to reduce healthcare costs by promoting non-biased prescriber education.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	2411	An Act providing prescription drug cost reimbursements to elderly governmental retirees.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	1981	An Act relative to school-located influenza vaccination programs.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	3817	An Act relative to substance use treatment, education, and prevention.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	604	An Act establishing a public health option.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	519	An Act relative to ensuring transparency of health plan formularies.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	875	An Act relative to a minimum creditable coverage advisory commission.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	625	An Act relative to patient access.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	1888	An Act relative to diabetes prevention and the creation of a diabetes state action plan.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	1027	An Act relative to prescription drugs.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	1986	An Act providing for unused medication return by health care facilities.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	2081	An Act establishing caregiver advise, record, and enable (CARE) Act.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	605	An Act to define modest meals and refreshments in prescriber education settings.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	2022	An Act relative to the safe disposal of prescription drugs.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Executive		Senate budget amendment on Health Insurance Consumer Protections. Senate budget amendment to mandate that the office of Medicaid shall investigate and provide a report on potential cost savings for prescription medications including, but not limited to, the feasibility of joining a Medicaid multistate prescription drug bulk purchase consortium and pursuing new supplemental rebates from prescription drug manufacturers. –Direct involvement with the State’s Health Policy Commission (HPC) as a formal member of the Health Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council focused, for the most part, on health care price variation, Rx drug costs both gross and net, as well as Accountable Care Organizations (ACO’s). Organizing and executing legislative tours of our corporate Research & Development laboratory facilities in the Commonwealth of MA. Also routinely communicated any and all activities	Neutral	$35,000.00	I had no business association with any public official I lobbied during this period.
Senate Bill	1188	An Act to reduce health care costs by promoting evidenced-based prescriber education.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	1937	An Act relative to the Safe disposal of Prescription drugs.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	362	An Act relative to the prescription drug coverage for seniors and the disabled.	Support	$571.42	I had no business association with any public official I lobbied during this period.
House Bill	870	An Act to ensure access to generic medications.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
Senate Bill	606	An Act to keep people healthy by removing barriers to cost-effective care.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
House Bill	791	An Act relative to patient medication adherence.	Support	$571.42	I had no business association with any public official I lobbied during this period.
Senate Bill	1042	An Act relative to responsible stewardship by drug manufacturers.	Oppose	$3,000.00	I had no business association with any public official I lobbied during this period.
House Bill	2072	An Act ensuring a representative health care cost containment discussion.	Neutral	$190.47	I had no business association with any public official I lobbied during this period.
			Total amount	$91,399.75

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
03/14/2016	Kate Hogan	State Representative, Third Middlesex	$200.00
03/15/2016	Jay Livingstone	State Representative, Eighth Suffolk	$100.00
03/21/2016	James Welch	State Senator, Hampden	$200.00
03/28/2016	Brad Jones	State Representative, Twentieth Middlesex	$200.00
03/28/2016	Denise Garlick	State Representative, Thirteenth Norfolk	$200.00
03/28/2016	Brian Dempsey	State Representative, Third Essex	$200.00
03/31/2016	Robert DeLeo	State Representative, Nineteenth Suffolk	$100.00
03/31/2016	Jen Flanagan	State Senator, Worcester and Middlesex	$200.00
04/06/2016	Barbara L'Italien	State Senator, Second Essex and Middlesex	$200.00
04/11/2016	Robert DeLeo	State Representative, Nineteenth Suffolk	$100.00
04/12/2016	Mark Cusack	State Representative, Fifth Norfolk	$200.00
04/12/2016	Ann Margaret Ferrante	State Representative, Fifth Essex	$200.00
04/12/2016	Jeffrey Sanchez	State Representative, Fifteenth Suffolk	$200.00
04/19/2016	John Lawn	State Representative, Tenth Middlesex	$200.00
05/02/2016	Karen Spilka	State Senator, Second Middlesex and Norfolk	$200.00
05/03/2016	Daniel Cullinane	State Representative, Twelfth Suffolk	$200.00
05/09/2016	Sal DiDomenico	State Senator, Middlesex and Suffolk	$200.00
05/18/2016	House Democratic Committee	House Democratic Committee	$200.00
		Total contributions	$3,300.00

Close this page

Connect with Us